Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-12-15 Sale |
2020-12-17 4:20 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
134,278 | $8.32 | $1,117,193 | 1,654,087 (Direct) |
View |
2020-12-11 Sale |
2020-12-15 5:35 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Senior VP, Chief Legal Officer |
13,741 | $7.96 | $109,378 | 108,061 (Direct) |
View |
2020-12-04 Sale |
2020-12-08 4:12 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Senior VP, Chief Legal Officer |
13,741 | $6.23 | $85,606 | 121,802 (Direct) |
View |
2020-08-11 Purchase |
2020-08-12 4:31 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
54,000 | $4.08 | $220,320 | 54,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-02-19 Tax Withholding |
2021-02-23 4:25 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
22,431 | $11.53 | 183,156 (Direct) |
View |
2021-02-19 Exercise |
2021-02-23 4:25 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
50,000 | $4.15 | 183,156 (Direct) |
View |
2021-02-19 Exercise |
2021-02-23 4:25 pm |
2012-03-01 2021-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
50,000 | $0 | 183,156 (Direct) |
View |
2020-12-15 Option Award |
2020-12-17 4:45 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Sniecinski Megan Chief Business Officer |
225,000 | $0 | 225,000 (Direct) |
View |
2020-12-15 Option Award |
2020-12-17 4:41 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
30,000 | $0 | 30,000 (Direct) |
View |
2020-12-15 Option Award |
2020-12-17 4:37 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Gayer Charles K Vice President and CCO |
190,000 | $0 | 190,000 (Direct) |
View |
2020-12-15 Option Award |
2020-12-17 4:32 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Senior VP, Chief Legal Officer |
280,000 | $0 | 280,000 (Direct) |
View |
2020-12-15 Option Award |
2020-12-17 4:30 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
280,000 | $0 | 280,000 (Direct) |
View |
2020-12-15 Option Award |
2020-12-17 4:27 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Sheridan William P Senior VP - CMO |
335,000 | $0 | 335,000 (Direct) |
View |
2020-12-15 Option Award |
2020-12-17 4:23 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Doyle Anthony Chief Financial Officer |
332,500 | $0 | 332,500 (Direct) |
View |
2020-12-15 Option Award |
2020-12-17 4:20 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
870,000 | $0 | 1,654,087 (Direct) |
View |
2020-12-15 Exercise |
2020-12-17 4:20 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
134,278 | $4.15 | 1,654,087 (Direct) |
View |
2020-12-15 Exercise |
2020-12-17 4:20 pm |
2012-03-01 2021-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
134,278 | $0 | 1,654,087 (Direct) |
View |
2020-12-11 Exercise |
2020-12-15 5:35 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Senior VP, Chief Legal Officer |
13,741 | $4.15 | 108,061 (Direct) |
View |
2020-12-11 Exercise |
2020-12-15 5:35 pm |
2012-03-01 2021-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Senior VP, Chief Legal Officer |
13,741 | $0 | 108,061 (Direct) |
View |
2020-12-04 Exercise |
2020-12-08 4:12 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Senior VP, Chief Legal Officer |
13,741 | $4.15 | 121,802 (Direct) |
View |
2020-12-04 Exercise |
2020-12-08 4:12 pm |
2012-03-01 2021-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Senior VP, Chief Legal Officer |
13,741 | $0 | 121,802 (Direct) |
View |
2020-12-03 Option Award |
2020-12-07 4:24 pm |
2020-12-03 2023-08-08 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
5,000 | $0 | 5,000 (Direct) |
View |
2020-12-03 Option Award |
2020-12-07 4:23 pm |
2020-12-03 2023-08-08 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Sheridan William P Senior VP - CMO |
17,000 | $0 | 17,000 (Direct) |
View |
2020-12-03 Option Award |
2020-12-07 4:21 pm |
2020-12-03 2023-08-08 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Barnes Alane P Senior VP, Chief Legal Officer |
17,000 | $0 | 17,000 (Direct) |
View |
2020-12-03 Option Award |
2020-12-07 4:19 pm |
2020-12-03 2023-08-08 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
17,000 | $0 | 17,000 (Direct) |
View |
2020-12-03 Option Award |
2020-12-07 4:16 pm |
2020-12-03 2023-08-08 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Stonehouse Jon P President & CEO |
182,250 | $0 | 182,250 (Direct) |
View |
2020-11-30 Option Award |
2020-12-02 4:21 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
978 | $5.11 | 13,386 (Direct) |
View |
2020-11-30 Option Award |
2020-12-02 4:19 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
1,956 | $5.11 | 30,569 (Direct) |
View |
2020-11-30 Option Award |
2020-12-02 4:16 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director |
978 | $5.11 | 64,293 (Direct) |
View |
2020-11-30 Option Award |
2020-12-02 4:14 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | INGRAM ROBERT ALEXANDER Director |
3,669 | $5.11 | 73,274 (Direct) |
View |
2020-08-31 Option Award |
2020-09-02 4:44 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Hutson Nancy J Director |
1,204 | $4.15 | 63,315 (Direct) |
View |
2020-08-31 Option Award |
2020-09-02 4:39 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | HEGGIE THERESA Director |
1,204 | $4.15 | 12,408 (Direct) |
View |
2020-08-31 Option Award |
2020-09-02 4:36 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director |
2,409 | $4.15 | 28,613 (Direct) |
View |
2020-08-31 Option Award |
2020-09-02 4:33 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | INGRAM ROBERT ALEXANDER Director |
4,518 | $4.15 | 69,605 (Direct) |
View |